David S Tierney's Net Worth
$5.26 Million
Who is David S Tierney?
David S Tierney has an estimated net worth of $5.26 Million. This is based on reported shares across multiple companies, which include CATALYST PHARMACEUTICALS, INC., Valera Pharmaceuticals Inc, BioPharmX Corp, ZEVRA THERAPEUTICS, INC., NEXMED INC, BIOJECT MEDICAL TECHNOLOGIES INC, and ABLE LABORATORIES INC.
SEC CIK
David S Tierney's CIK is 0001292636
Past Insider Trading and Trends
2007 was David S Tierney's most active year for acquiring shares with 12 total transactions. David S Tierney's most active month to acquire stocks was the month of November. 2007 was David S Tierney's most active year for disposing of shares, totalling 8 transactions. David S Tierney's most active month to dispose stocks was the month of March. 2018 saw David S Tierney paying a total of $1,648,250.00 for 7,605,000 shares, this is the most they've acquired in one year. In 2023 David S Tierney cashed out on 134,000 shares for a total of $1,171,150.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
CATALYST PHARMACEUTICALS, INC. (CPRX) Snapshot price: $13.56
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$9.84 | -$291,750.00 | 348.87K |
Apr 8
| |||
Form 4
| +1.16% | 4K |
—
|
—
| 348.87K |
Feb 15
| |||
Form 4
| +2.99% | 10K |
$1.13 | $11,300.00 | 344.87K |
Jan 2
| |||
Form 4
| +0.40% | 1.33K |
—
|
—
| 334.87K |
Dec 27
| |||
Form 4
|
—
|
0
|
$7.23 | -$609,750.00 | 333.54K |
Dec 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 8
| |||
Form 4
| +6.38% | 20K |
$0.79 | $15,800.00 | 333.54K |
May 11
| |||
Form 4
|
—
|
0
|
$8.81 | -$481,200.00 | 313.54K |
Apr 5
| |||
Form 4
| +1.29% | 4K |
—
|
—
| 313.54K |
Feb 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 27
| |||
Form 4
| +0.43% | 1.33K |
—
|
—
| 309.54K |
Dec 6
| |||
Form 4
|
—
|
0
|
$8.35 | -$232,580.00 | 308.21K |
Aug 22
| |||
Form 4
|
—
|
0
|
$2.53 | $50,600.00 | 308.21K |
May 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 28
| |||
Form 4
| +0.43% | 1.33K |
—
|
—
| 308.21K |
Dec 3
| |||
Form 4
|
—
|
0
|
$4.60 | -$147,895.00 | 306.87K |
Aug 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 30
| |||
Form 4
| +0.44% | 1.33K |
—
|
—
| 306.87K |
Dec 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
| +16.00% | 42.14K |
$0.47 | $23,500.00 | 305.54K |
Nov 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 30
| |||
Form 4
| +8.22% | 20K |
$1.09 | $32,700.00 | 263.4K |
Oct 27
| |||
Form 4
| +14.06% | 30K |
$0.90 | $27,000.00 | 243.4K |
Oct 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 28
| |||
Form 4
| +3.89% | 8K |
$2.03 | $16,240.00 | 213.4K |
Oct 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 12
| |||
Form 4
| +10.79% | 20K |
$0.58 | $11,696.00 | 205.4K |
May 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 20
| |||
Form 4
| +1.64% | 3K |
$1.55 | $4,650.00 | 185.4K |
Mar 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Valera Pharmaceuticals Inc No price found
President and CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -106.50K |
—
|
—
|
0
|
Apr 17
| |||
Form 4
| +1,538.46% | 100K |
$3.00 | $300,000.00 | 106.5K |
Apr 2
| |||
Form 4
| +18.18% | 1K |
$7.73 | $7,730.00 | 6.5K |
May 25
| |||
Form 4
|
∞
| 5.5K |
$9.00 | $49,500.00 | 5.5K |
Feb 1 - Feb 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
BioPharmX Corp (TMBR) No price found
Pres and CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 12
| |||
Form 4
| +1.35% | 100K |
$0.20 | $20,250.00 | 7.5M |
Sep 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ZEVRA THERAPEUTICS, INC. (ZVRA) Snapshot price: $5.7699
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +85.69% | 5K |
$4.15 | $20,731.50 | 10.84K |
Mar 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 28
| |||
Form 4
| +52.15% | 2K |
$4.39 | $8,780.00 | 5.83K |
May 25
| |||
Form 4
| +108.99% | 2K |
$7.79 | $15,578.00 | 3.83K |
Nov 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
| +51.62% | 10K |
$0.65 | $6,531.75 | 29.37K |
Aug 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 19
| |||
Form 4
| +49.66% | 6.43K |
—
|
—
| 19.37K |
Jun 30
| |||
Form 4
| +115.73% | 6.94K |
—
|
—
| 12.94K |
May 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 23
| |||
Form 4
| +20.00% | 1K |
$4.20 | $4,199.90 | 6K |
Mar 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 25
| |||
Form 4
|
∞
| 5K |
$11.00 | $55,000.00 | 5K |
Apr 21
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
NEXMED INC (SEEL) Snapshot price: $0.7728
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +4.16% | 10.71K |
$1.47 | $15,740.76 | 267.95K |
Oct 6
| |||
Form 4
| +4.34% | 10.71K |
$1.47 | $15,740.76 | 257.24K |
Jun 9
| |||
Form 4
| +9.51% | 21.42K |
$1.47 | $31,481.52 | 246.53K |
Feb 9
| |||
Form 4
| +5.32% | 11.36K |
$0.13 | $1,477.32 | 225.12K |
Sep 15
| |||
Form 4
| +49.03% | 70.32K |
$1.47 | $103,370.40 | 213.75K |
Aug 12
| |||
Form 4
| +7.68% | 10.23K |
$0.88 | $8,999.76 | 143.43K |
Dec 31
| |||
Form 4
| +22.34% | 24.32K |
$1.48 | $35,999.52 | 133.21K |
Jan 9
| |||
Form 4
| +25.43% | 20K |
$1.60 | $32,000.00 | 98.65K |
Sep 12
| |||
Form 4
| +10.37% | 10.23K |
$0.88 | $8,999.76 | 108.88K |
Sep 28
| |||
Form 4
| +17.50% | 10.23K |
$0.88 | $8,999.76 | 68.65K |
Jun 28
| |||
Form 4
| +21.22% | 10.23K |
$0.88 | $8,999.76 | 58.43K |
Apr 1
| |||
Form 4
| +164.84% | 30K |
—
|
—
| 48.2K |
Feb 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||